Poland · Delayed Price · Currency is PLN Diagnostyka Statistics
Total Valuation
Diagnostyka has a market cap or net worth of PLN 5.37 billion. The enterprise value is 6.59 billion.
| Market Cap | 5.37B |
| Enterprise Value | 6.59B |
Important Dates
The next confirmed earnings date is Thursday, November 26, 2026.
| Earnings Date | Nov 26, 2026 |
| Ex-Dividend Date | Jun 1, 2026 |
Share Statistics
Diagnostyka has 33.76 million shares outstanding.
| Current Share Class | 33.76M |
| Shares Outstanding | 33.76M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 51.42% |
| Owned by Institutions (%) | 25.11% |
| Float | 16.40M |
Valuation Ratios
The trailing PE ratio is 21.06 and the forward PE ratio is 17.75. Diagnostyka's PEG ratio is 0.52.
| PE Ratio | 21.06 |
| Forward PE | 17.75 |
| PS Ratio | 2.08 |
| PB Ratio | 10.18 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 16.89 |
| P/OCF Ratio | 10.33 |
| PEG Ratio | 0.52 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.87, with an EV/FCF ratio of 20.73.
| EV / Earnings | 25.85 |
| EV / Sales | 2.55 |
| EV / EBITDA | 10.87 |
| EV / EBIT | 17.09 |
| EV / FCF | 20.73 |
Financial Position
The company has a current ratio of 0.81, with a Debt / Equity ratio of 2.32.
| Current Ratio | 0.81 |
| Quick Ratio | 0.70 |
| Debt / Equity | 2.32 |
| Debt / EBITDA | 2.01 |
| Debt / FCF | 3.84 |
| Interest Coverage | 5.58 |
Financial Efficiency
Return on equity (ROE) is 55.37% and return on invested capital (ROIC) is 18.72%.
| Return on Equity (ROE) | 55.37% |
| Return on Assets (ROA) | 11.77% |
| Return on Invested Capital (ROIC) | 18.72% |
| Return on Capital Employed (ROCE) | 23.07% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 298,964 |
| Profits Per Employee | 29,483 |
| Employee Count | 8,645 |
| Asset Turnover | 1.26 |
| Inventory Turnover | 10.28 |
Taxes
In the past 12 months, Diagnostyka has paid 54.10 million in taxes.
| Income Tax | 54.10M |
| Effective Tax Rate | 16.88% |
Stock Price Statistics
The stock price has decreased by -12.15% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -12.15% |
| 50-Day Moving Average | 164.46 |
| 200-Day Moving Average | 171.48 |
| Relative Strength Index (RSI) | 44.42 |
| Average Volume (20 Days) | 26,174 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Diagnostyka had revenue of PLN 2.58 billion and earned 254.88 million in profits. Earnings per share was 7.55.
| Revenue | 2.58B |
| Gross Profit | 2.03B |
| Operating Income | 385.82M |
| Pretax Income | 320.49M |
| Net Income | 254.88M |
| EBITDA | 606.27M |
| EBIT | 385.82M |
| Earnings Per Share (EPS) | 7.55 |
Balance Sheet
The company has 17.56 million in cash and 1.22 billion in debt, with a net cash position of -1.20 billion or -35.67 per share.
| Cash & Cash Equivalents | 17.56M |
| Total Debt | 1.22B |
| Net Cash | -1.20B |
| Net Cash Per Share | -35.67 |
| Equity (Book Value) | 527.32M |
| Book Value Per Share | 15.11 |
| Working Capital | -103.55M |
Cash Flow
In the last 12 months, operating cash flow was 519.58 million and capital expenditures -201.74 million, giving a free cash flow of 317.84 million.
| Operating Cash Flow | 519.58M |
| Capital Expenditures | -201.74M |
| Depreciation & Amortization | 220.45M |
| Net Borrowing | -25.84M |
| Free Cash Flow | 317.84M |
| FCF Per Share | 9.42 |
Margins
Gross margin is 78.63%, with operating and profit margins of 14.93% and 9.86%.
| Gross Margin | 78.63% |
| Operating Margin | 14.93% |
| Pretax Margin | 12.40% |
| Profit Margin | 9.86% |
| EBITDA Margin | 23.46% |
| EBIT Margin | 14.93% |
| FCF Margin | 12.30% |
Dividends & Yields
This stock pays an annual dividend of 4.40, which amounts to a dividend yield of 2.77%.
| Dividend Per Share | 4.40 |
| Dividend Yield | 2.77% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 58.27% |
| FCF Payout Ratio | 46.73% |
| Buyback Yield | n/a |
| Shareholder Yield | 2.77% |
| Earnings Yield | 4.75% |
| FCF Yield | 5.92% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Diagnostyka is 196.39, which is 23.52% higher than the current price. The consensus rating is "Buy".
| Price Target | 196.39 |
| Price Target Difference | 23.52% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 12.13% |
| EPS Growth Forecast (3Y) | 15.77% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Diagnostyka has an Altman Z-Score of 3.96 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.96 |
| Piotroski F-Score | 5 |